Literature DB >> 8507079

Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate.

W Schramm1, M Spannagl, K A Bauer, R D Rosenberg, B Birkner, Y Linnau, H P Schwarz.   

Abstract

BACKGROUND AND DESIGN--Protein C is a vitamin K-dependent plasma protein that is converted to the serine protease activated protein C by the thrombin-thrombomodulin complex. Activated protein C functions as a natural anticoagulant by inactivating the cofactors of the coagulation cascade, factors Va and VIIIa. Coumarin (warfarin)-induced skin necrosis is thought to be due to a rapid elimination of protein C relative to other vitamin K-dependent factors during the initial phase of oral anticoagulation. We have used a highly purified protein C concentrate to treat a patient with acquired protein C deficiency who developed skin necrosis during the initial phase of oral anticoagulant therapy. OBSERVATIONS AND CONCLUSIONS--During protein C concentrate therapy, no further skin lesions appeared, and the healing process of necrotic areas was facilitated. Replacement therapy with protein C concentrate appears to be safe and effective as an adjunctive treatment for coumarin-induced skin necrosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8507079

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  14 in total

1.  Extensive coumarin-induced skin necrosis in a patient with acquired protein C deficiency.

Authors:  L Argaud; C Guerin; L Thomas; G Fournier
Journal:  Intensive Care Med       Date:  2001-09       Impact factor: 17.440

Review 2.  Inherited thrombophilia: memorandum from a joint WHO/International Society on Thrombosis and Haemostasis meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.

Authors:  J Petäjä; J A Fernández; A Gruber; J H Griffin
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

4.  Warfarin-Induced Skin Necrosis in the Presence of Acute Hepatic Injury and May-Thurner Syndrome.

Authors:  Carrie Tilton; Spencer Livengood; Jeremy Hodges; Jessica Marshall
Journal:  Hosp Pharm       Date:  2018-05-18

Review 5.  Clinical utilization of the international normalized ratio (INR).

Authors:  R S Riley; D Rowe; L M Fisher
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

6.  Purpura fulminans in severe congenital protein C deficiency: monitoring of treatment with protein C concentrate.

Authors:  F M Müller; W Ehrenthal; G Hafner; D Schranz
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

7.  Transgenic mice expressing recombinant human protein C exhibit defects in lactation and impaired mammary gland development.

Authors:  Carol A Palmer; Henryk Lubon; James L McManaman
Journal:  Transgenic Res       Date:  2003-06       Impact factor: 2.788

8.  [Impending Coumarin-necrosis in a patient with heterozygous protein C deficiency type I].

Authors:  R Schulze; W Behr; H Wittwer; S Harwix; K Murmann; W V Scheidt; W Ehret; G Schlimok
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

9.  Fulminant meningococcal septic shock in a boy with combined inherited properdin and protein C deficiency.

Authors:  C A Fijen; B H Derkx; E J Kuijper; M Mannens; S R Poort; M Peters; M R Daha; J Dankert
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications.

Authors:  Paul N Knoebl
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.